About Arivale
Arivale is a Healthcare company based in Seattle (United States) founded in 2014. Provider of direct-to-consumer genetic testing. Arivale has raised $49.6 million across 2 funding rounds from investors including Arch Venture Partners, Polaris Partners and Maveron. Its focus areas include Life Sciences, Genomics, Applied Genomics and Consumer Genomics. Its legal entity is ARIVALE INC. Its competitors include Helix, Counsyl and InformedDNA; 3 of its 3 listed competitors have raised funding.
Company details
Arivale was established in 2014 in Seattle, United States, within the bioscience sector. Testing of consumers genomes, blood, saliva, gut microbiomes, and lifestyles is conducted through direct-to-consumer services. Data from these analyses is processed to deliver tailored fitness and nutritional guidance. Operations focus on integrating genetic, clinical, and environmental factors for individualized health insights, with biotech pioneer Lee Hood among the founders.
- Headquarters Seattle, United States
- SectorsHealthcare
- Website arivale.com
- Social LinkedIn X
- Legal Name Arivale Inc.
- Total Equity Funding$49.6M (USD)
in 2 rounds
- Latest Funding Round$13.6M (USD), Series C
Jun 2017
- InvestorsArch Venture Partners
& 2 more
Funding Insights of Arivale
Arivale has successfully raised a total of $49.6M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $13.6 million completed in June 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $49.6M
- Total Rounds 2
- Last Round Series C — $13.6M
- First Round $36M
(Jul 2015)
- Investors Count 3
All 2 funding rounds of Arivale with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2017 | $13.6M | Series C | – | – | – |
| Jul 2015 | $36M | Series B | – | Maveron |
3 investors in total: 3 institutional.
Investors in Arivale
Arivale has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Arch Venture Partners, Polaris Partners and Maveron.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
US focused venture capital firm | polarispartners.com | Boston, United States | ||
Venture capital firm focused on life science companies | 1986 | archventure.com | Chicago, United States | |
Venture capital investments in consumer businesses, emphasizing technology and human behavior. | maveron.com |
Investor details for Arivale
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Arivale
3 dated milestones of Arivale across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Arivale is founded.
- Funding First funding round of $36.0M.
- Funding Latest funding round, Series C, of $13.6M.
Competitors of Arivale
Arivale has 3 listed competitors in our database, 3 of them funded. They include Helix, Counsyl and InformedDNA.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| helix.com | 2015 | San Francisco, United States | $435M | Genomic database for clinical research is provided. | ||
| counsyl.com | 2007 | San Francisco, United States | $112.89M | 503 | DNA mapping for pre-pregnancy genetic testing, DNA and cancer screening | |
| informeddna.com | 2007 | St Petersburg, United States | $19.22M | Network of genetics experts provided to assist patients and providers. |
Detailed competitors of Arivale
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Arivale (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Arivale
Complete news archive for Arivale
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Arivale
Arivale was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Arivale is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Arivale is a funded company, having raised a total of $49.6M across 2 funding rounds to date. The company's 1st funding round was a Series B of $36M, raised on Jul 2015.
Arivale was established in 2014 in Seattle, United States, within the bioscience sector. Testing of consumers genomes, blood, saliva, gut microbiomes, and lifestyles is conducted through direct-to-consumer services. Data from these analyses is processed to deliver tailored fitness and nutritional guidance. Operations focus on integrating genetic, clinical, and environmental factors for individualized health insights, with biotech pioneer Lee Hood among the founders.
Arivale's top competitors include Helix, InformedDNA and Counsyl.
Arivale has 3 investors. Key investors include Arch Venture Partners, Polaris Partners, and Maveron.
Arivale operates through Arivale Inc..